| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $56.4M | +35.1% |
| SG&A Expense | $19.0M | +2.0% |
| Operating Income | -$73.6M | -81.7% |
| Interest Expense | $3.3M | +5.5% |
| Net Income | -$70.5M | -88.7% |
| EPS (Basic) | -$1.63 | -55.2% |
| EPS (Diluted) | -$1.63 | -55.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $111.0M | -17.4% |
| Current Assets | $113.1M | -18.3% |
| Total Assets | $126.9M | -27.4% |
| Current Liabilities | $15.2M | -21.7% |
| Long-term Debt | $32.1M | -19.8% |
| Total Liabilities | $53.5M | -15.6% |
| Stockholders' Equity | $73.4M | -34.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.2M | -72.3% |
| Capital Expenditures | $254K | -67.0% |
| Investing Cash Flow | -$254K | +67.0% |
| Financing Cash Flow | $13.1M | -77.6% |
| Free Cash Flow | -$56.4M | -69.1% |